"Mr. Paxton has a checkered background. He is a conman and a fraud ... Indonesia, India and Vietnam, for example, aren't retaliating against Trump's tariffs, Greer said. Other major trading ...

I initiate coverage on Merck & Co., Inc. with a Strong Buy rating and a $139 price target, driven by resilient execution and robust product depth. Merck is growing pharma sales and expanding ...

The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension ... Winrevair added to maximum background therapy reduced the risk of all-cause death, lung transplantation ...

Despite mixed performance, Merck's stock has dropped 37% since mid-2024, but I maintain a buy rating due to long-term support and potential growth drivers. Merck's Q4 results beat expectations ...

Prakash Mishra, Head of Vietnam SLS Commercial at Merck Vietnam, remarked, "The quality of visitors this year has been very good we've met professionals from across Asia, Europe, and even the US ...

Merck MRK announced that the FDA has accepted its regulatory filing seeking approval for the subcutaneous (under the skin or SC) formulation of the blockbuster drug Keytruda (pembrolizumab).

RAHWAY, N.J., April 01, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2025 sales and earnings conference call with ...

By Damien Cave Reporting from Ho Chi Minh City, Vietnam The Trump administration has told its senior diplomats in Vietnam not to take part in events marking the 50th anniversary of the end of the war.

SIOUX FALLS, S.D. (KELO) — This year marks 50 years since the end of the Vietnam War. For many who fought in Vietnam, their years since the fall of Saigon have been spent coping with physical ...